Ceftazidime and Nephropathy toxic - a phase IV clinical study of FDA data

Summary:

Nephropathy toxic is reported as a side effect among people who take Ceftazidime (ceftazidime), especially for people who are male, 10-19 old, have been taking the drug for < 1 month also take Vancomycin, and have Pseudomonas infection.

The phase IV clinical study analyzes which people have Nephropathy toxic when taking Ceftazidime. It is created by eHealthMe based on reports of 10,307 people who have side effects when taking Ceftazidime from the FDA, and is updated regularly.

What is Ceftazidime?

Ceftazidime has active ingredients of ceftazidime. eHealthMe is studying from 10,327 Ceftazidime users. Check the latest studies of Ceftazidime.

What is Nephropathy toxic?

Nephropathy toxic (damage to kidney due to toxins) is found to be associated with 596 drugs and 737 conditions by eHealthMe. Check the latest studies of Nephropathy toxic.

On Jul, 13, 2026

10,307 people reported to have side effects when taking Ceftazidime.
Among them, 40 people (0.39%) have Nephropathy toxic.

Could Ceftazidime cause Nephropathy toxic?

Among these 40 people:

How long have people been on Ceftazidime when they have Nephropathy toxic? *

What is the gender of people who have Nephropathy toxic when taking Ceftazidime? *

female: 44.44 %
male: 55.56 %

What is the age of people who have Nephropathy toxic when taking Ceftazidime? *

What are other drugs people take besides Ceftazidime? *

Vancomycin: 21 people, 52.50%
Cyclosporine: 7 people, 17.50%
Zithromax: 5 people, 12.50%
Furosemide: 5 people, 12.50%
Piperacillin And Tazobactam: 5 people, 12.50%
Prednisone: 5 people, 12.50%
Minocycline Hydrochloride: 5 people, 12.50%
Vfend: 4 people, 10.00%
Tacrolimus: 4 people, 10.00%
Medrol: 4 people, 10.00%

What are other side effects people have besides Nephropathy toxic? *

Ascites (accumulation of fluid in the abdominal cavity): 8 people, 20.00%
Pleural Effusion (water on the lungs): 8 people, 20.00%
Weight Increased: 7 people, 17.50%
Metabolic Acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body): 7 people, 17.50%
Generalised Oedema (swelling all over the body): 7 people, 17.50%
Acute Kidney Failure: 6 people, 15.00%
Urine Output - Decreased: 6 people, 15.00%
Pneumonia: 6 people, 15.00%
Respiratory Alkalosis (elevated blood ph due to excess breathing): 6 people, 15.00%
Blood Creatinine Increased: 5 people, 12.50%

What are the existing conditions these people have? *

Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 8 people, 20.00%
Device Related Infection: 7 people, 17.50%
Staphylococcal Infection (an infection with staphylococcus bacteria): 6 people, 15.00%
Pneumocystis Jiroveci Pneumonia (fungal infection of the lungs): 4 people, 10.00%
Febrile Neutropenia (fever with reduced white blood cells): 3 people, 7.50%
Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges): 2 people, 5.00%
Cystic Fibrosis (disease of the secretary glands): 1 person, 2.50%
Erysipelas (bacterial skin infection): 1 person, 2.50%
Enterobacter Infection (infection caused by bacteria of the family enterobacteriaceae): 1 person, 2.50%
Drug Toxicity: 1 person, 2.50%

* Approximation only. Some reports may have incomplete information.

Do you take Ceftazidime and have Nephropathy toxic?

- Check whether Nephropathy toxic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ceftazidime:

Ceftazidime (10,327 reports)

Browse all side effects of Ceftazidime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nephropathy toxic:

Nephropathy toxic (596 drugs)

Browse all the conditions that are associated with Nephropathy toxic:

Nephropathy toxic (737 conditions)

Related publications that referenced our studies

Chen F, Zhan Z, "Severe drug-induced immune haemolytic anaemia due to ceftazidime", Blood Transfusion, 2014 Jan .
Chen F, Zhan Z, "Severe drug-induced immune haemolytic anaemia due to ceftazidime", Blood Transfusion, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on ceftazidime (the active ingredients of Ceftazidime) and Ceftazidime (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.